Ryvu Therapeutics S.A. Announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced total revenue was PLN 6.553 million compared to PLN 13.515 million a year ago. Operating loss was PLN 15.655 million compared to PLN 4.967 million a year ago. Net loss was PLN 13.563 million compared to PLN 4.307 million a year ago.